⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30903815 | 1.00 | — | — | |
| SCHEMBL30903816 | 1.00 | — | — | |
| SCHEMBL30578990 | 0.82 | KCNH2 (0.39) | — | |
| SCHEMBL1400836 | 0.82 | KCNH2 (0.39) | — | |
| SCHEMBL486201 | 0.82 | CCR1 (0.55) | — | |
| SCHEMBL14835224 | 0.79 | KCNH2 (0.43) | — | |
| SCHEMBL29712341 | 0.78 | — | — | |
| SCHEMBL378811 | 0.78 | — | — | |
| SCHEMBL7430287 | 0.76 | ESR1 (0.41) | — | |
| SCHEMBL10577578 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113979955-B | Preparation method of heterocyclic ester compound | 河南农业大学 | 2024-05-14 | — | — | CN | claimed |
| CN-113979955-A | Preparation method of heterocyclic ester compound | 河南农业大学 | 2022-01-28 | — | — | CN | claimed |
| EP-1304325-A1 | 5-(M-CYANOBENZYLAMINO)PYRAZOLE DERIVATIVES | Sankyo Company, Limited (JP) | 2003-04-23 | — | — | EP | claimed |
| EP-0301403-B1 | CURING AGENT FOR SYNTHETIC RESINS, COMPOSITIONS CONTAINING THE SAME AND USES OF THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-07-15 | — | — | EP | claimed |
| US-4847346-A | HYDROXYALKYLPYRIDINE BLOCKED DIISOCYANATES AS CURING AGENTS | HOECHST AG (DE) | 1989-07-11 | — | — | US | claimed |
| EP-0301403-A2 | Curing agent for synthetic resins, compositions containing the same and uses of them | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-01 | — | — | EP | claimed |
| US-12534458-B2 | Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors | MERCK SHARP & DOHME LLC (US) | 2026-01-27 | — | — | US | disclosed |
| WO-2025137541-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | NEURON23, INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| WO-2025101652-A1 | SELECTIVE MAMMALIAN STERILE 20-LIKE KINASE 1 (MST1) MODULATOR COMPOUNDS AS THERAPEUTICS FOR DIABETES AND LIVER REGENERATION | THE SCRIPPS RESEARCH INSTITUTE (US) | 2025-05-15 | — | — | WO | disclosed |
| US-20250144093-A1 | PYRUVATE KINASE ACTIVATORS FOR USE IN TREATING BLOOD DISORDERS | AGIOS PHARMACEUTICALS, INC. | 2025-05-08 | — | — | US | disclosed |
| US-20250101012-A1 | HETEROCYCLE SUBSTITUTED PYRIDINE DERIVATIVE ANTIFUNGAL AGENTS | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2025-03-27 | — | — | US | disclosed |
| US-12139479-B2 | Heterocycle substituted pyridine derivative antifungal agents | BASILEA PHARMACEUTICA INTERNATIONAL AG, ALLSCHWIL (CH) | 2024-11-12 | — | — | US | disclosed |
| US-20240368147-A1 | CYCLIN K DEGRADER | ADLAI NORTYE BIOPHARMA CO., LTD. (CN) | 2024-11-07 | — | — | US | disclosed |
| EP-0313630-A1 | SUBSTITUTED 2-ACYLPYRIDIN-ALPHA-(N)-HETARYLHYDRAZONES AND MEDICAMENTS CONTAINING SAME. | DEUTSCHES AUSSATZIGEN HILFSWER (DE) | 1989-05-03 | — | — | EP | disclosed |
| US-4826833-A | ANTIBIOTICS | PFIZER INC. (US) | 1989-05-02 | — | — | US | disclosed |
| EP-0301403-A2 | Curing agent for synthetic resins, compositions containing the same and uses of them | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-02-01 | — | — | EP | disclosed |
| US-4749574-A | MICROCAPSULE OF 2-NITROXYMETHYL-6-CHLOROPYRINE OR ITS OCCLUSION COMPOUND WITH B-CYCLODEXTRIN | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1988-06-07 | — | — | US | disclosed |
| EP-0241806-A1 | Sustained-release transdermal delivery preparations | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1987-10-21 | — | — | EP | disclosed |
| EP-0193164-A2 | Sustained-release pharmaceutical preparation which comprised 2-nitroxy-methyl-6-chloropyridine, process for its preparation and use thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1986-09-03 | — | — | EP | disclosed |
| EP-0150984-A2 | 6-(Substituted) methylenepenicillanic and 6-(substituted) hydroxymethylpenicillanic acids and derivatives thereof | PFIZER INC. (US) | 1985-08-07 | — | — | EP | disclosed |